FILTER

FILTERED INTERVIEW RESULTS

Mickey Kertesz

FOUNDER & CEO, KARIUS
The Karius test harnesses next-generation sequencing to detect fragments of cell-free DNA from bacteria, viruses, fungi and protozoa that may be circulating in a patient’s bloodstream.

William Hait

GLOBAL HEAD, JOHNSON & JOHNSON GLOBAL EXTERNAL INNOVATION
Johnson & Johnson invested US$10 billion in research and development in 2017 both internally and externally.

Joseph Colleluori

SENIOR VICE PRESIDENT CORPORATE DEVELOPMENT, LONZA GROUP
Headquartered in Switzerland and traded on the Swiss stock exchange, Lonza is a leading supplier to the pharma and biotech industries.

Brian Frenzel

PRESIDENT AND CEO, TOSK, INC.
Tosk, Inc. is a small molecule, oncology drug discovery and development company.

Peter Parker

MANAGING GENERAL PARTNER, BIOINNOVATION CAPITAL AND CO-FOUNDER AND DIRECTOR, LABCENTRAL
LabCental offers life science companies in Massachusetts at an early stage the facilities they need to develop

David Cory

CEO, EIGER BIOPHARMACEUTICALS
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.

Barbara Weber

CEO, TANGO THERAPEUTICS
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.

Michael Bigham & Evan Loh

PARATEK PHARMACEUTICALS
Paratek focuses on drugs that target infectious disease and other difficult-to-treat conditions.

Richard Peters

PRESIDENT AND CEO, MERRIMACK PHARMACEUTICALS
Merrimack Pharmaceuticals is focused on cancer treatment through a deeper understanding of cancer pathways and biological markers.

Ankit Mahadevia & Cristina Larkin

CEO & CHIEF COMMERCIAL OFFICER, SPERO THERAPEUTICS
Spero Therapeutics is developing new antimicrobial drugs to substitute those that have become ineffectual as they meeting resistance.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

USA Mining 2025-26 - Pre-release

USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.

PARTNER EVENTS